Dr. Flinn on the iNNOVATE Trial in Waldenstrom Macroglobulinemia

(1:42)

Prostate Cancer Clinical Trial: The INNOVATE Trial (NRG-GU008)

(3:21)

iNNOVATE trial of added ibrutinib for Waldenströms Macroglobulinemia

(6:7)

iNNOVATE trial of added ibrutinib for Waldenströms Macroglobulinemia

(3:11)

CAPTIVATE and iNNOVATE Clinical Trial Results for CLL

(2:37)

INCLUDE: Innovation in Clinical Trial Design and Delivery for the Underserved

(9:1econd)

INNOVATE: a clinical trial about improving prostate cancer diagnosis!

(9:9)

2021 Neuroscience Symposium | Breaking Update: ALS Clinical Trials

(25:42)

Summarize the findings from the final analysis of the phase III INNOVATE trial of ibrutinib in WM

(4:2)

Innovation in clinical trial design

(1:2:50)

Innovating Clinical Trials: Operational Innovation

(20:30)

iNNOVATE results: a prospective new standard of care for Waldenström’s

(1:32)

Innovation in clinical trials: WINTHER trial

(4:34)

PwC intelligent clinical trial design: bring medicines to market faster

(1:41)

Trial Innovation Unit

(5:15)

Accelerating Clinical Trials: Innovative Clinical Trial Designs, with an Intro to Bayesian Thinking

(41:51)

George Berci: Trials, Triumphs, Innovations

(56:43)

iNNOVATE study update: long-term PFS in WM

(1:34)

AWS re:Invent 2019: Enhancing clinical trials with machine learning (LFS203)

(44:46)

Innovation in Digitally Enabled Clinical Trials

(1:31:1econd)